Several studies have found VEGF levels to be significantly higher in the tissues and biological fluids of women with ovarian cancer compared with healthy controls [17–20], whereas its association with tumour progression and/or patient survival is still controversial. The gene discussed is VEGFA; the disease is ovarian cancer.